Home » The FDA authorizes the first drug to treat severe food allergies

The FDA authorizes the first drug to treat severe food allergies

by admin
The FDA authorizes the first drug to treat severe food allergies

New Study Finds Asthma Drug May Help Protect Against Deadly Food Allergies

A groundbreaking study published in the New England Journal of Medicine has revealed that a drug commonly used to treat asthma may also provide protection against dangerous and potentially deadly multiple food allergies. The drug, known as Xolair in the US and omalizumab in chemical terms, was tested on 118 children with known peanut and other food allergies.

The results of the study showed that 67 percent of the children who received the drug were able to tolerate a small amount of peanut protein without experiencing any symptoms. In contrast, only 7 percent of children who were given a placebo were able to do the same. This promising outcome led to the recent approval by the US Food and Drug Administration (FDA) for the use of Xolair in adults and one-year-olds with food allergies.

Despite the positive findings, researchers caution that the drug is not a cure-all for food allergies and that individuals should still avoid known allergens. However, the drug has the potential to reduce the risk of dangerous allergic reactions for those who live in constant fear of accidental exposure to allergens.

Dr. Robert Wood of Johns Hopkins University School of Medicine, one of the researchers involved in the study, described the treatment as “life-changing” for individuals who face the threat of severe allergic reactions. In the US alone, severe allergic reactions lead to approximately 30,000 emergency room visits each year.

Xolair is administered through injections every few weeks, making the treatment regimen somewhat complex. Despite this, the potential benefits for individuals with food allergies could be significant, offering hope for a safer and more manageable future. Stay updated on this and other important news by subscribing to our Telegram channel for the latest updates on Economic Scenarios articles.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy